{"id":"W2913605978","doi":"10.1016/j.ejvs.2018.11.008","title":"PLX-PAD Cell Treatment of Critical Limb Ischaemia: Rationale and Design of the PACE Trial","year":2019,"lang":"en","type":"article","venue":"European Journal of Vascular and Endovascular Surgery","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":44,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"Horizon 2020; Bayer Canada; AstraZeneca Schweiz; Terumo BCT; United States - Israel Binational Agricultural Research and Development Fund; Dan Jansen Foundation; Fresenius Biotech; Amgen; Pfizer; Merck; Bristol-Myers Squibb; Mitsubishi International Corporation","keywords":"Medicine; Clinical endpoint; Clinical trial; Tolerability; Placebo; Critical limb ischemia; Amputation; Surgery; Internal medicine; Adverse effect; Vascular disease; Arterial disease; Pathology","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003647312,0.001179447,0.002370987,0.0004444106,0.000341907,0.001443762,0.0006045183,0.001903726,0.004274268],"category_scores_gemma":[0.002350087,0.0003485833,0.001538307,0.000544372,0.00114525,0.0009155187,0.0005083423,0.002970876,0.001131797],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004636355,"about_ca_system_score_gemma":0.0008835463,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001456876,"about_ca_topic_score_gemma":0.0002730482,"domain_scores_codex":[0.9988033,0.0006077068,0.00009148154,0.0001736753,0.000129573,0.0001944074],"domain_scores_gemma":[0.9993935,0.0002159005,0.00009882551,0.00007619794,0.00004473273,0.0001709262],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"not_applicable","study_design_scores_codex":[0.8183697,0.007129116,0.003606808,0.002825857,0.002014008,0.0002509334,0.000137324,0.002605986,0.01213393,0.005977632,0.00450213,0.1404466],"study_design_scores_gemma":[0.7851745,0.1758258,0.006210794,0.0004431256,0.001697929,0.0001873178,0.00008316807,0.00116938,0.003083135,0.004534686,0.02153129,0.00005878889],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"protocol","genre_scores_codex":[0.8915069,0.03401797,0.008886757,0.005716198,0.003960714,0.02601104,0.003462616,0.0002532335,0.02618472],"genre_scores_gemma":[0.9051259,0.01701384,0.01154163,0.005951054,0.002864303,0.043128,0.002034179,0.00008204375,0.01225909],"genre_candidate":"protocol","genre_consensus":null,"teacher_disagreement_score":0.004274268,"threshold_uncertainty_score":0.01928908,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02337146066055147,"score_gpt":0.2326471690357974,"score_spread":0.2092757083752459,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}